Long COVID affects about 6.9% of adults, according to the CDC, and women are slightly more likely than men to get it. In June, a Stanford (Calif.) Medicine study of 155 patients with moderate to severe COVID found that taking Paxlovid for 15 days was safe, but didn’t reduce symptoms of long COVID.
But a study published Jan. 6 in Communications Medicine found Paxlovid could help some patients. The study had 13 patients with long COVID take Paxlovid for seven to 30 days. The results were mixed: Nine patients reported improvement, but only five said it lasted, while four reported no improvement at all.
So far, there has been no widely effective treatment found for long COVID.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
